Anti Obesity Drugs Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
Anti Obesity Drugs Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
The research report on ‘Anti Obesity Drugs Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report elaborates the market size, market characteristics, and market growth of the Anti Obesity Drugs industry, and breaks down according to the type, application, and consumption area of Anti Obesity Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Anti Obesity Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Anti Obesity Drugs market covered in Chapter 13:
Vivus
GlaxoSmithKline
Pfizer
F Hoffmann-La Roche
Bayer AG
Currax Pharmaceuticals
Novo Nordisk
In Chapter 6, on the basis of types, the Anti Obesity Drugs market from 2015 to 2025 is primarily split into:
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
In Chapter 7, on the basis of applications, the Anti Obesity Drugs market from 2015 to 2025 covers:
Prescription Drugs
OTC drugs
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Anti Obesity Drugs Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Anti Obesity Drugs Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Anti Obesity Drugs Market Forces
3.1 Global Anti Obesity Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Anti Obesity Drugs Market - By Geography
4.1 Global Anti Obesity Drugs Market Value and Market Share by Regions
4.1.1 Global Anti Obesity Drugs Value ($) by Region (2015-2020)
4.1.2 Global Anti Obesity Drugs Value Market Share by Regions (2015-2020)
4.2 Global Anti Obesity Drugs Market Production and Market Share by Major Countries
4.2.1 Global Anti Obesity Drugs Production by Major Countries (2015-2020)
4.2.2 Global Anti Obesity Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Anti Obesity Drugs Market Consumption and Market Share by Regions
4.3.1 Global Anti Obesity Drugs Consumption by Regions (2015-2020)
4.3.2 Global Anti Obesity Drugs Consumption Market Share by Regions (2015-2020)
5 Anti Obesity Drugs Market - By Trade Statistics
5.1 Global Anti Obesity Drugs Export and Import
5.2 United States Anti Obesity Drugs Export and Import (2015-2020)
5.3 Europe Anti Obesity Drugs Export and Import (2015-2020)
5.4 China Anti Obesity Drugs Export and Import (2015-2020)
5.5 Japan Anti Obesity Drugs Export and Import (2015-2020)
5.6 India Anti Obesity Drugs Export and Import (2015-2020)
5.7
6 Anti Obesity Drugs Market - By Type
6.1 Global Anti Obesity Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Anti Obesity Drugs Production by Types (2015-2020)
6.1.2 Global Anti Obesity Drugs Production Market Share by Types (2015-2020)
6.2 Global Anti Obesity Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Anti Obesity Drugs Value by Types (2015-2020)
6.2.2 Global Anti Obesity Drugs Value Market Share by Types (2015-2020)
6.3 Global Anti Obesity Drugs Production, Price and Growth Rate of Peripherally Acting Anti-obesity Drugs (2015-2020)
6.4 Global Anti Obesity Drugs Production, Price and Growth Rate of Centrally Acting Anti-obesity Drugs (2015-2020)
7 Anti Obesity Drugs Market - By Application
7.1 Global Anti Obesity Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Anti Obesity Drugs Consumption by Applications (2015-2020)
7.1.2 Global Anti Obesity Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Anti Obesity Drugs Consumption and Growth Rate of Prescription Drugs (2015-2020)
7.3 Global Anti Obesity Drugs Consumption and Growth Rate of OTC drugs (2015-2020)
8 North America Anti Obesity Drugs Market
8.1 North America Anti Obesity Drugs Market Size
8.2 United States Anti Obesity Drugs Market Size
8.3 Canada Anti Obesity Drugs Market Size
8.4 Mexico Anti Obesity Drugs Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Anti Obesity Drugs Market Analysis
9.1 Europe Anti Obesity Drugs Market Size
9.2 Germany Anti Obesity Drugs Market Size
9.3 United Kingdom Anti Obesity Drugs Market Size
9.4 France Anti Obesity Drugs Market Size
9.5 Italy Anti Obesity Drugs Market Size
9.6 Spain Anti Obesity Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Anti Obesity Drugs Market Analysis
10.1 Asia-Pacific Anti Obesity Drugs Market Size
10.2 China Anti Obesity Drugs Market Size
10.3 Japan Anti Obesity Drugs Market Size
10.4 South Korea Anti Obesity Drugs Market Size
10.5 Southeast Asia Anti Obesity Drugs Market Size
10.6 India Anti Obesity Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Anti Obesity Drugs Market Analysis
11.1 Middle East and Africa Anti Obesity Drugs Market Size
11.2 Saudi Arabia Anti Obesity Drugs Market Size
11.3 UAE Anti Obesity Drugs Market Size
11.4 South Africa Anti Obesity Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Anti Obesity Drugs Market Analysis
12.1 South America Anti Obesity Drugs Market Size
12.2 Brazil Anti Obesity Drugs Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Vivus
13.1.1 Vivus Basic Information
13.1.2 Vivus Product Profiles, Application and Specification
13.1.3 Vivus Anti Obesity Drugs Market Performance (2015-2020)
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Basic Information
13.2.2 GlaxoSmithKline Product Profiles, Application and Specification
13.2.3 GlaxoSmithKline Anti Obesity Drugs Market Performance (2015-2020)
13.3 Pfizer
13.3.1 Pfizer Basic Information
13.3.2 Pfizer Product Profiles, Application and Specification
13.3.3 Pfizer Anti Obesity Drugs Market Performance (2015-2020)
13.4 F Hoffmann-La Roche
13.4.1 F Hoffmann-La Roche Basic Information
13.4.2 F Hoffmann-La Roche Product Profiles, Application and Specification
13.4.3 F Hoffmann-La Roche Anti Obesity Drugs Market Performance (2015-2020)
13.5 Bayer AG
13.5.1 Bayer AG Basic Information
13.5.2 Bayer AG Product Profiles, Application and Specification
13.5.3 Bayer AG Anti Obesity Drugs Market Performance (2015-2020)
13.6 Currax Pharmaceuticals
13.6.1 Currax Pharmaceuticals Basic Information
13.6.2 Currax Pharmaceuticals Product Profiles, Application and Specification
13.6.3 Currax Pharmaceuticals Anti Obesity Drugs Market Performance (2015-2020)
13.7 Novo Nordisk
13.7.1 Novo Nordisk Basic Information
13.7.2 Novo Nordisk Product Profiles, Application and Specification
13.7.3 Novo Nordisk Anti Obesity Drugs Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Anti Obesity Drugs Market Forecast (2020-2025)
14.2 Europe Anti Obesity Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Anti Obesity Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Anti Obesity Drugs Market Forecast (2020-2025)
14.5 South America Anti Obesity Drugs Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Anti Obesity Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Anti Obesity Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Anti Obesity Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Anti Obesity Drugs Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Anti Obesity Drugs Picture
Table Anti Obesity Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Anti Obesity Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Anti Obesity Drugs Value ($) and Growth Rate (2015-2020)
Table Global Anti Obesity Drugs Value ($) by Countries (2015-2020)
Table Global Anti Obesity Drugs Value Market Share by Regions (2015-2020)
Figure Global Anti Obesity Drugs Value Market Share by Regions in 2019
Figure Global Anti Obesity Drugs Production and Growth Rate (2015-2020)
Table Global Anti Obesity Drugs Production by Major Countries (2015-2020)
Table Global Anti Obesity Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Anti Obesity Drugs Production Market Share by Regions in 2019
Figure Global Anti Obesity Drugs Consumption and Growth Rate (2015-2020)
Table Global Anti Obesity Drugs Consumption by Regions (2015-2020)
Table Global Anti Obesity Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Anti Obesity Drugs Consumption Market Share by Regions in 2019
Table Global Anti Obesity Drugs Export Top 3 Country 2019
Table Global Anti Obesity Drugs Import Top 3 Country 2019
Table United States Anti Obesity Drugs Export and Import (2015-2020)
Table Europe Anti Obesity Drugs Export and Import (2015-2020)
Table China Anti Obesity Drugs Export and Import (2015-2020)
Table Japan Anti Obesity Drugs Export and Import (2015-2020)
Table India Anti Obesity Drugs Export and Import (2015-2020)
Table Global Anti Obesity Drugs Production by Types (2015-2020)
Table Global Anti Obesity Drugs Production Market Share by Types (2015-2020)
Figure Global Anti Obesity Drugs Production Share by Type (2015-2020)
Table Global Anti Obesity Drugs Value by Types (2015-2020)
Table Global Anti Obesity Drugs Value Market Share by Types (2015-2020)
Figure Global Anti Obesity Drugs Value Share by Type (2015-2020)
Figure Global Peripherally Acting Anti-obesity Drugs Production and Growth Rate (2015-2020)
Figure Global Peripherally Acting Anti-obesity Drugs Price (2015-2020)
Figure Global Centrally Acting Anti-obesity Drugs Production and Growth Rate (2015-2020)
Figure Global Centrally Acting Anti-obesity Drugs Price (2015-2020)
Table Global Anti Obesity Drugs Consumption by Applications (2015-2020)
Table Global Anti Obesity Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Anti Obesity Drugs Consumption Share by Application (2015-2020)
Figure Global Prescription Drugs Consumption and Growth Rate (2015-2020)
Figure Global OTC drugs Consumption and Growth Rate (2015-2020)
Figure North America Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Anti Obesity Drugs Consumption by Countries (2015-2020)
Table North America Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Anti Obesity Drugs Consumption by Countries (2015-2020)
Table Europe Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Anti Obesity Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure China Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Anti Obesity Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Anti Obesity Drugs Consumption by Countries (2015-2020)
Table South America Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Anti Obesity Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Anti Obesity Drugs Market Consumption and Growth Rate (2015-2020)
Table Vivus Company Profile
Table Vivus Production, Value, Price, Gross Margin 2015-2020
Figure Vivus Production and Growth Rate
Figure Vivus Value ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table F Hoffmann-La Roche Company Profile
Table F Hoffmann-La Roche Production, Value, Price, Gross Margin 2015-2020
Figure F Hoffmann-La Roche Production and Growth Rate
Figure F Hoffmann-La Roche Value ($) Market Share 2015-2020
Table Bayer AG Company Profile
Table Bayer AG Production, Value, Price, Gross Margin 2015-2020
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2015-2020
Table Currax Pharmaceuticals Company Profile
Table Currax Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Currax Pharmaceuticals Production and Growth Rate
Figure Currax Pharmaceuticals Value ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Production, Value, Price, Gross Margin 2015-2020
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Anti Obesity Drugs Market Forecast Production by Types (2020-2025)
Table Global Anti Obesity Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Anti Obesity Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Anti Obesity Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Anti Obesity Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Anti Obesity Drugs Market Forecast Consumption Share by Applications (2020-2025)
Research Methodology:
Anti Obesity Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|